ESMO 2023: Focus on Lung Cancer
ESMO 2023: Focus on Lung Cancer
Advertisement
Mary GreccoESMO 2023: Focus on Lung Cancer | February 28, 2024
Results of a study explored the potential of automated lung tumor vascularity.
Read More
Mary GreccoESMO 2023: Focus on Lung Cancer | February 28, 2024
A study assessed unmet needs as well as QOL and FT in survivors of NSCLC.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 28, 2024
A study assessed differences in lung cancer screening eligibility among lung cancer survivors.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 26, 2024
Depression is common in patients with lung cancer and those with type 2 diabetes.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 26, 2024
VOCs are known to be associated with lung cancer, and EGFR mutations are common in lung adenocarcinoma.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 23, 2024
A study examined the impact of the Interception-Lung program, which aims to reduce the incidence of advanced lung cancer.
Mary GreccoNon-Small Cell Lung Cancer | February 23, 2024
A study evaluated the prognosis of patients with locally advanced and metastatic NSCLC who underwent prior TKI.
Mary GreccoESMO 2023: Focus on Lung Cancer | February 23, 2024
The study aimed to investigate the relationship between tobacco use and lung cancer.
Mary GreccoNon-Small Cell Lung Cancer | February 23, 2024
The TROPION-Lung07 trial will evaluate Dato-DXd plus pembrolizumab in patients with advanced/metastatic NSCLC.
Mary GreccoESMO 2023: Focus on Lung Cancer | January 31, 2024
A study analyzed the clinicopathological characteristics of small-scale ROS1 mutations in patients with NSCLC.
Mary GreccoESMO 2023: Focus on Lung Cancer | January 31, 2024
A study looked at the modulating effects of neoadjuvant immunotherapy and CRT on TDLN in patients with T2-4NO-1 NSCLC.
Mary GreccoESMO 2023: Focus on Lung Cancer | January 31, 2024
A study compared IMPT with IMRT its impact on hematological toxicity and effect on durvalumab treatment on NSCLC.
Mary GreccoESMO 2023: Focus on Lung Cancer | January 31, 2024
A study investigated the overlap between patients with COPD and patients examined on suspicion of lung cancer.
Mary GreccoESMO 2023: Focus on Lung Cancer | January 31, 2024
Results of a study examining the association between HRD status and postsurgical therapeutic options in early-stage NSCLC.
Mary GreccoESMO 2023: Focus on Lung Cancer | January 31, 2024
Results of a study that sought to determine a dynamic pattern of ctDNA during hypofractionated radiation therapy.
Mary GreccoESMO 2023: Focus on Lung Cancer | January 31, 2024
A study investigated the use of a structured multidisciplinary review for the diagnosis of IO pneumonitis in NSCLC.
Mary GreccoESMO 2023: Focus on Lung Cancer | January 30, 2024
A study used a preoperative machine learning model to predict lung cancer recurrence.
Mary GreccoESMO 2023: Focus on Lung Cancer | January 30, 2024
Targeted therapies and platinum-based chemotherapy may become ineffective in patients with a/mNSCLC with AGAs.
Advertisement
Advertisement
Advertisement
Latest News

April 24, 2024